10 May 2024 in Frontiers in Immunology
Hepatocellular carcinoma (HCC) is a significant contributor to cancer-related deaths in the world. The development and progression of HCC are closely correlated with the abnormal regulation of non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs). Important biological pathways in cancer biology, such as cell proliferation, death, and metastasis, are impacted by these ncRNAs, which modulate gene expression. The abnormal expression of non-coding RNAs in HCC raises the possibility that they could be applied as new biomarkers for diagnosis, prognosis, and treatment targets. Furthermore, by controlling the expression of cancer-related genes, miRNAs can function as either tumor suppressors or oncogenes. On the other hand, lncRNAs play a role in the advancement of cancer by interacting with other molecules within the cell, which, in turn, affects processes such as chromatin remodeling, transcription, and post-transcriptional processes. The importance of ncRNA-driven regulatory systems in HCC is being highlighted by current research, which sheds light on tumor behavior and therapy response. This research highlights the great potential of ncRNAs to improve patient outcomes in this difficult disease landscape by augmenting the present methods of HCC care through the use of precision medicine approaches.
18 January 2024 in Cell Biology International
1 October 2019 in Annals of Oncology
There is increasing evidence that long non-coding RNAs (lncRNAs) are involved in tumor biology and development. The chromosome 8q24.21 locus is one of the most frequently amplified genomic regions in colon cancer, and many cancer-associated lncRNAs have been found in this 8q24 region. In this study, CASC21, located at 8q24.21, was selected to further experiments in colon cancer. First, we downloaded RNA-sequencing data from the Cancer Genome Atlas (TCGA) database and analyzed the lncRNA expression profile in colon cancer. Then, CASC21, a lncRNA located at 8q24.21,was selected for further experiments. We performed qRT-PCR to detect the expression of CASC21 in colon cancer tissues and cell lines. Fluorescence in situ hybridization (FISH) assay was used to analyze the location of CASC21 in cells. Loss of function assays were used to test the efficacy of CASC21 on proliferation and invasion in colon cancer. Animal experiments including tumorigenicity studies and in vivo metastasis assays were used to determine the roles of CASC21 in tumor growth and metastasis in vivo. We found that CASC21 was significantly upregulated in colon cancer tissues compared with corresponding normal tissues. Up-regulation of CASC21 was associated with the tumor -node -metastasis (TNM) stage in colon cancer. Similarly, CASC21 was upregulated in colon cancer cell lines compared with colon epithelial cell line. FISH testing showed that CASC21 mainly located in the cytoplasm rather than the nucleus. Loss of function assays revealed that CASC21 knockdown significantly inhibited cell growth by inducing cell apoptosis and cell cycle arrest. Additionally, CASC21 knockdown promoted cell metastasis by facilitating epithelial mesenchymal transformation (EMT). Moreover, CASC21 expression was significant positively associated with MYC expression in both TCGA data and our cohort. Western blot assays showed that knockdown of CASC21 markedly reduced the expression levels of WNT targets including c-myc, β-catenin and cyclinD1. Animal studies also demonstrated that CASC21 promoted tumor growth and metastasis in colon cancer. Our results provide the first evidence that CASC21 is a novel oncogenic regulator and a potential therapeutic target in colon cancer. Xiaoping Qian. Has not received any funding. All authors have declared no conflicts of interest.
11 October 2016 in Annals of Oncology
Background: Recent studies have suggested that KRAS plays an important role in gastric cancer. The aim of this study was to assess the prognostic effect of KRAS mutation and expression levels in gastric cancer patients and to explore its potential role in targeted therapy.